Ann Y. Lee

1.3k total citations
50 papers, 825 citations indexed

About

Ann Y. Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ann Y. Lee has authored 50 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Epidemiology. Recurrent topics in Ann Y. Lee's work include Cutaneous Melanoma Detection and Management (9 papers), Gastric Cancer Management and Outcomes (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Ann Y. Lee is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Gastric Cancer Management and Outcomes (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Ann Y. Lee collaborates with scholars based in United States, Canada and Chile. Ann Y. Lee's co-authors include Nina Bowens, Edward A. Kravitz, Robert Huber, Selby Chen, Mary S. Brady, Russell S. Berman, Aimeé M. Crago, Narasimhan P. Agaram, Mark N. Levine and Samuel Singer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Clinical Oncology.

In The Last Decade

Ann Y. Lee

47 papers receiving 812 citations

Peers

Ann Y. Lee
Christine H. Kim United States
Jennifer Shoemaker United States
Matthew Morgan United States
M Osame Japan
Ann Y. Lee
Citations per year, relative to Ann Y. Lee Ann Y. Lee (= 1×) peers Friedrich Weber

Countries citing papers authored by Ann Y. Lee

Since Specialization
Citations

This map shows the geographic impact of Ann Y. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Y. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Y. Lee more than expected).

Fields of papers citing papers by Ann Y. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Y. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Y. Lee. The network helps show where Ann Y. Lee may publish in the future.

Co-authorship network of co-authors of Ann Y. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Y. Lee. A scholar is included among the top collaborators of Ann Y. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Y. Lee. Ann Y. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urnov, Fyodor D., Sadik H. Kassim, Kiran Musunuru, et al.. (2025). Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher. Cytotherapy. 27(10). 1151–1163. 2 indexed citations
2.
Kassim, Sadik H., Fyodor D. Urnov, Kiran Musunuru, et al.. (2025). Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable. Nature Biotechnology. 43(7). 1047–1049. 2 indexed citations
3.
Cohen, Steven M., Christopher L. Wolfgang, Greg D. Sacks, et al.. (2023). Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database. Journal of Surgical Oncology. 128(2). 262–270. 4 indexed citations
4.
Sacks, Greg D., et al.. (2023). Time to Curative-Intent Surgery in Gastric Cancer Shows a Bimodal Relationship with Overall Survival. Journal of Gastrointestinal Surgery. 27(5). 855–865. 2 indexed citations
5.
Wang, Annie, Rachel Lee, Maria C. Russell, et al.. (2022). Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis. Journal of Surgical Oncology. 126(4). 649–657. 1 indexed citations
7.
Vitiello, Gerardo A., Steven M. Cohen, Christopher L. Wolfgang, et al.. (2022). Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis. Annals of Surgical Oncology. 29(6). 3522–3531. 7 indexed citations
8.
Kronenfeld, Joshua P., Amber L. Collier, Annie Wang, et al.. (2021). Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety‐Net Collaborative analysis. Journal of Surgical Oncology. 124(8). 1317–1328. 7 indexed citations
9.
Lee, Rachel, Matthew R. Porembka, Joshua P. Kronenfeld, et al.. (2021). Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?. Journal of Surgical Oncology. 124(4). 551–559. 3 indexed citations
10.
Vitiello, Gerardo A., Erica B. Friedman, James Sun, et al.. (2021). Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. Cancer Control. 28. 2895471615–2895471615. 16 indexed citations
11.
Ryon, Emily L., Joshua P. Kronenfeld, Rachel Lee, et al.. (2020). Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis. Journal of Surgical Oncology. 123(2). 407–415. 10 indexed citations
12.
Bartlett, Edmund K., Ann Y. Lee, Philip M. Spanheimer, et al.. (2020). Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. British journal of surgery. 107(11). 1480–1488. 9 indexed citations
13.
Lee, Rachel, Adriana C. Gamboa, Adam C. Yopp, et al.. (2020). Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative. Surgical Oncology. 35. 120–125. 7 indexed citations
14.
Lee, Ann Y. & Russell S. Berman. (2020). Management of Noncutaneous Melanomas. Surgical Oncology Clinics of North America. 29(3). 387–400. 4 indexed citations
15.
Kronenfeld, Joshua P., Emily L. Ryon, David S. Goldberg, et al.. (2020). Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis. HPB. 23(6). 868–876. 8 indexed citations
16.
Okada, Tomoyo, Ann Y. Lee, Li‐Xuan Qin, et al.. (2016). Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. Cancer Discovery. 6(10). 1148–1165. 68 indexed citations
17.
Lee, Ann Y., Beverly Y. Wang, & Keith S. Heller. (2010). Importance of intraoperative parathyroid hormone measurement in the diagnosis of parathyroid lipoadenoma. Head & Neck. 33(6). 917–919. 9 indexed citations
18.
Lee, Ann Y., et al.. (2008). The timing of surgery for cholecystitis: a review of 202 consecutive patients at a large municipal hospital. The American Journal of Surgery. 195(4). 467–470. 32 indexed citations
19.
Chen, Selby, Ann Y. Lee, Nina Bowens, Robert Huber, & Edward A. Kravitz. (2002). Fighting fruit flies: A model system for the study of aggression. Proceedings of the National Academy of Sciences. 99(8). 5664–5668. 287 indexed citations
20.
Lee, Ann Y., Joseph M. Connors, Paul Klimo, Sean OʼReilly, & R. D. Gascoyne. (1997). Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.. Journal of Clinical Oncology. 15(5). 1745–1753. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026